Management of Hypertriglyceridemia in Pregnancy

Introduction to Management

The American College of Cardiology recommends aggressive dietary intervention as first-line therapy for hypertriglyceridemia in pregnancy, with omega-3 fatty acids added when triglycerides exceed 500 mg/dL despite lifestyle modifications, and plasmapheresis reserved for severe cases or acute pancreatitis 1, 2

High-risk women, including those with poorly controlled diabetes mellitus, should have triglyceride levels checked once every trimester, with monthly monitoring initiated when fasting triglycerides exceed 250 mg/dL, according to the American Diabetes Association 3
Triglyceride levels rise progressively with each trimester, and women with baseline levels ≥500 mg/dL may develop severe hypertriglyceridemia during the third trimester, leading to pancreatitis risk, as reported by the American College of Cardiology 1

The American College of Cardiology recommends that all statins must be discontinued 1-2 months before planned pregnancy or immediately upon discovery of unplanned pregnancy, as they are contraindicated throughout gestation and breastfeeding 1, 3
Meta-analyses demonstrate increased miscarriage risk with statin exposure, though no clear teratogenic effects with pravastatin specifically, according to the American College of Cardiology 1
For very high-risk patients, pravastatin may be considered during pregnancy after careful risk-benefit discussion, as limited evidence suggests potential benefits for preeclampsia prevention, as reported by the American Diabetes Association 3, 4

The American Diabetes Association recommends implementing a strict low-carbohydrate, low-fat diet with total fat restricted to 25-30% of total calories for triglycerides 250-500 mg/dL 3, 5
Completely eliminating all added sugars and alcohol is recommended for triglycerides 250-500 mg/dL, according to the American Diabetes Association 3, 5
Restricting total dietary fat to <20 g/day or <15% of total calories under registered dietician guidance is recommended for triglycerides >500 mg/dL, as reported by the American College of Cardiology 2

Prescription omega-3 fatty acids should be initiated when fasting triglycerides exceed 500 mg/dL despite maximal dietary modifications, according to the American College of Cardiology 2
Omega-3 fatty acids have a better safety profile during pregnancy compared to other lipid-lowering agents, as reported by the American College of Cardiology 2

Plasmapheresis is the first-line acute intervention for hypertriglyceridemia-induced pancreatitis during pregnancy due to its ability to rapidly reduce triglyceride levels, according to the American College of Cardiology 2
Asymptomatic pregnant women with fasting triglycerides >1,000 mg/dL should undergo plasmapheresis, as recommended by the American College of Cardiology 2

The American College of Cardiology recommends not delaying intervention until pancreatitis develops, as maternal mortality from gestational hypertriglyceridemic pancreatitis approaches 20% 1, 3
The American Diabetes Association advises against using low-fat, high-carbohydrate diets without carbohydrate restriction, as excessive carbohydrates are converted to triglycerides 3, 5
The American College of Cardiology recommends not continuing statins during pregnancy, even in high-risk patients, without careful consideration and informed consent 1, 3

Management requires coordination between obstetrician, endocrinologist, gastroenterologist, lipid specialist, and registered dietician, according to the American College of Cardiology 2

The American College of Cardiology recommends resuming appropriate lipid-lowering therapy after delivery and completion of breastfeeding, with counseling on contraception if medications are restarted 2